These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 7480899)

  • 61. Safety and tolerability of iodixanol. A dimeric, nonionic contrast medium: an emphasis on European clinical phases I and II.
    Bolstad B; Borch KW; Grynne BH; Lundby B; Nossen JO; Kloster YF; Kristoffersen DT; Andrew E
    Invest Radiol; 1991 Nov; 26 Suppl 1():S201-4; discussion S208. PubMed ID: 1808130
    [No Abstract]   [Full Text] [Related]  

  • 62. The blood-brain barrier: effects of nonionic contrast media with and without addition of Ca2+ and Mg2+.
    Golman K
    Invest Radiol; 1979; 14(4):305-8. PubMed ID: 489270
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dose-related nephrotoxicity.
    Rosovsky M; Rusinek H
    Radiology; 2006 Aug; 240(2):614. PubMed ID: 16864686
    [No Abstract]   [Full Text] [Related]  

  • 64. Eosinophilia caused by iodinated radiographic contrast media.
    Plavsić B; Kuzmanić D; Rotkvić I
    Clin Radiol; 1983 Nov; 34(6):639-42. PubMed ID: 6689519
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of nonionic and ionic contrast agents in the rabbit lung.
    Moore DE; Carroll FE; Dutt PL; Reed GW; Holburn GE
    Invest Radiol; 1991 Feb; 26(2):134-42. PubMed ID: 2055713
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preliminary European intravenous clinical experience with a new, low osmolar, nonionic contrast medium: ioversol (Optiray).
    Le Mignon MM; Azau C; Arthaud A; Bonnemain B
    Eur J Radiol; 1991; 13(2):126-33. PubMed ID: 1743190
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Iodixanol injection: a nonionic, isosmolar, hexa-iodinated contrast agent. Symposium proceedings.
    Acad Radiol; 1996 Sep; 3 Suppl 3():S473-528. PubMed ID: 8883523
    [No Abstract]   [Full Text] [Related]  

  • 68. [Oral contrast media in CT: improvement by addition of guar?].
    Conrad R; Schneider G; Wilhelm K; Speck U; Schild H
    Rofo; 1997 Dec; 167(6):552-6. PubMed ID: 9465948
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Results of a double blind study of three contrast media and technic for lumbosacral radiculography.
    Hammer B
    Neuroradiology; 1978 Nov; 17(1):45-50. PubMed ID: 377130
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of a low osmolarity nonionic radiographic contrast agent with a standard medium on renal function in cyanotic and normal dogs.
    Pridjian AK; Bove EL; Beekman RH; Lupinetti FM
    Cathet Cardiovasc Diagn; 1994 Jan; 31(1):90-3. PubMed ID: 8118866
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Power injection of intravenous contrast material through central venous catheters for CT: in vitro evaluation.
    Herts BR; Cohen MA; McInroy B; Davros WJ; Zepp RC; Einstein DM
    Radiology; 1996 Sep; 200(3):731-5. PubMed ID: 8756923
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Brain parenchyma penetration by intrathecal ionic and nonionic contrast media.
    Sage MR; Wilcox J; Evill CA; Benness GT
    AJNR Am J Neuroradiol; 1982; 3(5):481-3. PubMed ID: 6814212
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Pulmonary oedema subsequent to radiographic contrast in a computed tomography of the coronary arteries].
    Plambech M; Garvey LH
    Ugeskr Laeger; 2012 May; 174(19):1316-7. PubMed ID: 22564693
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nonionic iodinated intravenous contrast material-related reactions: incidence in large urban children's hospital--retrospective analysis of data in 12,494 patients.
    Callahan MJ; Poznauskis L; Zurakowski D; Taylor GA
    Radiology; 2009 Mar; 250(3):674-81. PubMed ID: 19244041
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Late allergy-like reactions following vascular administration of radiography contrast media.
    Pedersen SH; Svaland MG; Reiss AL; Andrew E
    Acta Radiol; 1998 Jul; 39(4):344-8. PubMed ID: 9685816
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Delayed hypersensitivity reaction to the non-ionic X-ray contrast medium Visipaque (iodixanol).
    Sánchez-Pérez J; F-Villalta MG; Ruíz SA; García Diez A
    Contact Dermatitis; 2003 Mar; 48(3):167. PubMed ID: 12755737
    [No Abstract]   [Full Text] [Related]  

  • 77. No Association between Intravenous Contrast Material Exposure and Adverse Clinical Outcome: Are Prevention Protocols Effective?
    Gramberg MC; Penne EL
    Radiology; 2015 Oct; 277(1):306. PubMed ID: 26402500
    [No Abstract]   [Full Text] [Related]  

  • 78. Development of a life-threatening anaphylactoid reaction following administration of ioversol in a child.
    Zuckerman GB; Riess PL; Patel L; Constantinescu AR; Rosenfeld DL
    Pediatr Radiol; 1999 Apr; 29(4):295-7. PubMed ID: 10199911
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Late skin reaction to iodixanol (Visipaque): clinical manifestations, patch test study, and histopathological evaluation.
    Delgado-Jimenez Y; Perez-Gala S; Aragüés M; Sanchez-Perez J; Garcia-Diez A
    Contact Dermatitis; 2006 Dec; 55(6):348-53. PubMed ID: 17101010
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Induction of micronuclei in lymphocytes of patients undergoing excretory urography with ioversol.
    Cochran ST; Norman A
    Invest Radiol; 1994 Feb; 29(2):210-2. PubMed ID: 8169099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.